Patents by Inventor Jennifer Hyde

Jennifer Hyde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUBULAR IMPLANTS WITH CONTROLLED BIODEGRADATION
    Publication number: 20240293217
    Abstract: Implantable medical devices have zones of high in vivo stability that are adjacent to zones of relatively low in vivo stability, so that when these medical devices are implanted into a host, the zones of low in vivo stability degrade first and allow the formation of independent segments of relatively intact high in vivo stability bands that are sufficiently small that they may pass from the host in a non-harmful manner.
    Type: Application
    Filed: May 14, 2024
    Publication date: September 5, 2024
    Inventors: Jennifer Cartledge, Kenneth W. Clinkscales, Elizabeth Elvington, James Hyde, Brad Johns, Michael Scott Taylor
  • SNS-595 AND METHODS OF USING THE SAME
    Publication number: 20180316309
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: April 27, 2018
    Publication date: November 1, 2018
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • SNS-595 and methods of using the same
    Patent number: 9980949
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: May 29, 2018
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER
    Publication number: 20180098975
    Abstract: Methods of treating, preventing or managing cancer, including certain leukemias are disclosed. The methods encompass the administration of enantiomerically pure (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.
    Type: Application
    Filed: September 25, 2017
    Publication date: April 12, 2018
    Inventors: Daniel C. Adelman, Jeffrey A. Silverman, Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • SNS-595 AND METHODS OF USING THE SAME
    Publication number: 20170373636
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: August 18, 2014
    Publication date: December 28, 2017
    Inventors: MICHELLE ARKIN, JENNIFER HYDE, DUNCAN WALKER, JASMIN WRIGHT
  • SNS-595 AND METHODS OF USING THE SAME
    Publication number: 20150190381
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: August 18, 2014
    Publication date: July 9, 2015
    Inventors: MICHELLE ARKIN, JENNIFER HYDE, DUNCAN WALKER, JASMIN WRIGHT
  • SNS-595 and methods of using the same
    Patent number: 8822493
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: September 2, 2014
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER
    Publication number: 20140205680
    Abstract: Methods of treating, preventing or managing cancer, including certain leukemias are disclosed. The methods encompass the administration of enantiomerically pure (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.
    Type: Application
    Filed: October 17, 2013
    Publication date: July 24, 2014
    Applicant: SUNESIS PHARMACEUTICALS, INC.
    Inventors: Daniel C. Adelman, Jeffrey A. Silverman, Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • SNS-595 AND METHODS OF USING THE SAME
    Publication number: 20130244967
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: March 11, 2013
    Publication date: September 19, 2013
    Applicant: Sunesis Pharmaceuticals, Inc.
    Inventors: MICHELLE ARKIN, JENNIFER HYDE, DUNCAN WALKER, JASMIN WRIGHT
  • SNS-595 AND METHODS OF USING THE SAME
    Publication number: 20110263524
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: April 27, 2011
    Publication date: October 27, 2011
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
    Patent number: 7968565
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: June 28, 2011
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • Methods of using(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4 -oxo-1-(2-thiazolyl)- 1,8-naphthyridine-3-carboxylic acid for treatment of cancer
    Publication number: 20090263393
    Abstract: Methods of treating, preventing or managing cancer, including certain leukemias are disclosed. The methods encompass the administration of enantiomerically pure (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.
    Type: Application
    Filed: September 5, 2006
    Publication date: October 22, 2009
    Inventors: Daniel C. Adelman, Jeffrey A. Silverman, Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmine Wright
  • SNS-595 and methods of using the same
    Publication number: 20060063795
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: September 2, 2005
    Publication date: March 23, 2006
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • SNS-595 and methods of using the same
    Publication number: 20050215583
    Abstract: The present invention relates to SNS-595 and methods of treating cancer using the same.
    Type: Application
    Filed: March 14, 2005
    Publication date: September 29, 2005
    Inventors: Michelle Arkin, Jennifer Hyde, Duncan Walker, Jasmin Wright
  • Surface plasmon resonance methods
    Publication number: 20030186464
    Abstract: The present invention relates to the use of SPR methods to obtain information relating to molecular binding events. In one aspect of the present invention, methods are provided for determining whether a binding interaction is competitive or cooperative. In another aspect of the present invention, methods are provided for obtaining information where the binding interaction includes a formation of a reversible covalent bond.
    Type: Application
    Filed: January 29, 2003
    Publication date: October 2, 2003
    Inventors: Michelle Arkin, Jennifer Hyde, Brian Cunningham